Quarterly report pursuant to Section 13 or 15(d)

EQUITY (Tables)

v3.24.1.1.u2
EQUITY (Tables)
3 Months Ended
Mar. 31, 2024
EQUITY  
Summary of common shares reserved for future issuance

​

​

​

​

​

​

​

​

​

March 31, 

​

December 31, 

​

​

    

2024

    

2023

​

Warrants

 

13,456,328

 

13,595,987

​

Series 2 Convertible Preferred Shares

 

1,166,667

 

1,166,667

​

Options issued and outstanding under stock option plan

 

1,152,597

 

898,262

​

Deferred Share Units

 

1,061

 

1,061

​

Common Shares available for grant under stock option plan

 

2,639,626

 

471,843

​

Total Common Shares reserved for future issuance

 

18,416,279

 

16,133,820

​

Summary of fair value of the warrant liability

​

​

​

​

​

​

    

March 31, 

​

​

2024

Balance at December 31, 2023

​

$

94,185

Change in fair value of C$ warrant liability

​

​

14,133

Balance at March 31, 2024

​

$

108,318

​

A summary of warrant liability activity for the year ended December 31, 2023 is as follows:

​

​

​

​

​

​

​

December 31, 

​

​

2023

Balance at December 31, 2022

​

$

1,859,374

October 2022 PIPE warrant liability at issuance

​

 

—

Change in fair value of the warrant liability

​

 

(564,548)

Foreign exchange loss

​

 

(7,426)

Fair value of US$ warrant liability as of June 30, 2023

​

​

1,287,400

Fair value of previously liability-classified US$ warrants reclassified to additional paid-in-capital as of July 1, 2023

​

​

(1,287,400)

Fair value of previously equity-classified C$ warrants reclassified to warrant liability as of July 1, 2023

​

​

396,375

Change in fair value of C$ warrant liability

​

​

(302,190)

Balance at December 31, 2023

​

$

94,185